ABSTRACT

The paper explores the idea that the success of the Korean government’s non-pharmaceutical interventions in response to the COVID-19 epidemic can be better understood through the lens of industrial policy framework than many descriptive public policy literatures that have merely focused on administrative efficiency. It is emphasized in this paper that the Korean government has maintained sustained R&D support, tax subsidy, and various forms of public–private partnerships to help nurture and grow domestic infant industry in such strategic industrial areas as information-communication technology, biotechnology and health care, and pharmaceutical industry for a long time, and this soft industrial policy has enabled the public health authority to implement a series of successful non-pharmaceutical public health measures to suppress and mitigate the spread of the novel coronavirus.

摘要

本文探讨了通过产业政策框架的视角可以更好地理解韩国政府针对 COVID-19 流行病采取的非药物干预措施取得的成功，而不是许多仅关注行政效率的描述性公共政策文献。本文强调，韩国政府一直保持持续的研发支持、税收补贴和各种形式的公私合作伙伴关系，以帮助在信息通信技术、生物技术和医疗保健等战略性工业领域培育和发展国内婴儿产业。和制药行业长期以来，